Biocept offers circulating tumor cell (CTC) capture and enumeration along with molecular analysis for genomic profiling. We offer laboratory tests for CTC enumeration and CTC enumeration plus HER2 FISH.
Biocept consistently captures circulating tumor cells (CTCs) in patients with early-stage, metastatic or recurrent cancer. We offer laboratory tests for CTC enumeration and CTC enumeration plus HER2 FISH.
Biocept has entered into collaborations with several academic institutions and pharmaceutical or biotech companies to explore the application of the CEE system to research CTCs.